Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Poliovirus Vaccine Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Poliovirus Vaccine Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Inactivated Polio Vaccine (IPV)
      • 1.3.3 Oral Polio Vaccine (OPV)
    • 1.4 Market Segment by Application
      • 1.4.1 Global Poliovirus Vaccine Market Share by Application (2019-2025)
      • 1.4.2 Public
      • 1.4.3 Private
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Poliovirus Vaccine Market Size
      • 2.1.1 Global Poliovirus Vaccine Revenue 2014-2025
      • 2.1.2 Global Poliovirus Vaccine Sales 2014-2025
    • 2.2 Poliovirus Vaccine Growth Rate by Regions
      • 2.2.1 Global Poliovirus Vaccine Sales by Regions 2014-2019
      • 2.2.2 Global Poliovirus Vaccine Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Poliovirus Vaccine Sales by Manufacturers
      • 3.1.1 Poliovirus Vaccine Sales by Manufacturers 2014-2019
      • 3.1.2 Poliovirus Vaccine Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Poliovirus Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Poliovirus Vaccine Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Poliovirus Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.3 Poliovirus Vaccine Price by Manufacturers
    • 3.4 Key Manufacturers Poliovirus Vaccine Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Poliovirus Vaccine Market
    • 3.6 Key Manufacturers Poliovirus Vaccine Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Inactivated Polio Vaccine (IPV) Sales and Revenue (2014-2019)
      • 4.1.2 Oral Polio Vaccine (OPV) Sales and Revenue (2014-2019)
    • 4.2 Global Poliovirus Vaccine Sales Market Share by Type
    • 4.3 Global Poliovirus Vaccine Revenue Market Share by Type
    • 4.4 Poliovirus Vaccine Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Poliovirus Vaccine Sales by Application

    6 United States

    • 6.1 United States Poliovirus Vaccine Breakdown Data by Company
    • 6.2 United States Poliovirus Vaccine Breakdown Data by Type
    • 6.3 United States Poliovirus Vaccine Breakdown Data by Application

    7 European Union

    • 7.1 European Union Poliovirus Vaccine Breakdown Data by Company
    • 7.2 European Union Poliovirus Vaccine Breakdown Data by Type
    • 7.3 European Union Poliovirus Vaccine Breakdown Data by Application

    8 China

    • 8.1 China Poliovirus Vaccine Breakdown Data by Company
    • 8.2 China Poliovirus Vaccine Breakdown Data by Type
    • 8.3 China Poliovirus Vaccine Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Poliovirus Vaccine Breakdown Data by Company
    • 9.2 Rest of World Poliovirus Vaccine Breakdown Data by Type
    • 9.3 Rest of World Poliovirus Vaccine Breakdown Data by Application
    • 9.4 Rest of World Poliovirus Vaccine Breakdown Data by Countries
      • 9.4.1 Rest of World Poliovirus Vaccine Sales by Countries
      • 9.4.2 Rest of World Poliovirus Vaccine Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Sanofi
      • 10.1.1 Sanofi Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Poliovirus Vaccine
      • 10.1.4 Poliovirus Vaccine Product Introduction
      • 10.1.5 Sanofi Recent Development
    • 10.2 GSK
      • 10.2.1 GSK Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Poliovirus Vaccine
      • 10.2.4 Poliovirus Vaccine Product Introduction
      • 10.2.5 GSK Recent Development
    • 10.3 Bibcol
      • 10.3.1 Bibcol Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Poliovirus Vaccine
      • 10.3.4 Poliovirus Vaccine Product Introduction
      • 10.3.5 Bibcol Recent Development
    • 10.4 Serum Institute
      • 10.4.1 Serum Institute Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Poliovirus Vaccine
      • 10.4.4 Poliovirus Vaccine Product Introduction
      • 10.4.5 Serum Institute Recent Development
    • 10.5 Tiantan Biological
      • 10.5.1 Tiantan Biological Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Poliovirus Vaccine
      • 10.5.4 Poliovirus Vaccine Product Introduction
      • 10.5.5 Tiantan Biological Recent Development
    • 10.6 IMBCA
      • 10.6.1 IMBCA Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Poliovirus Vaccine
      • 10.6.4 Poliovirus Vaccine Product Introduction
      • 10.6.5 IMBCA Recent Development
    • 10.7 Panacea Biotec Ltd
      • 10.7.1 Panacea Biotec Ltd Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Poliovirus Vaccine
      • 10.7.4 Poliovirus Vaccine Product Introduction
      • 10.7.5 Panacea Biotec Ltd Recent Development
    • 10.8 Bio-Med
      • 10.8.1 Bio-Med Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Poliovirus Vaccine
      • 10.8.4 Poliovirus Vaccine Product Introduction
      • 10.8.5 Bio-Med Recent Development
    • 10.9 Halfkin Bio-Pharmaceuticals
      • 10.9.1 Halfkin Bio-Pharmaceuticals Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Poliovirus Vaccine
      • 10.9.4 Poliovirus Vaccine Product Introduction
      • 10.9.5 Halfkin Bio-Pharmaceuticals Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Poliovirus Vaccine Sales Channels
      • 11.2.2 Poliovirus Vaccine Distributors
    • 11.3 Poliovirus Vaccine Customers

    12 Market Forecast

    • 12.1 Global Poliovirus Vaccine Sales and Revenue Forecast 2019-2025
    • 12.2 Global Poliovirus Vaccine Sales Forecast by Type
    • 12.3 Global Poliovirus Vaccine Sales Forecast by Application
    • 12.4 Poliovirus Vaccine Forecast by Regions
      • 12.4.1 Global Poliovirus Vaccine Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Poliovirus Vaccine Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Poliovirus Vaccine is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Poliovirus Vaccine.

      This report studies the global market size of Poliovirus Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Poliovirus Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Sanofi
      GSK
      Bibcol
      Serum Institute
      Tiantan Biological
      IMBCA
      Panacea Biotec Ltd
      Bio-Med
      Halfkin Bio-Pharmaceuticals

      Market Segment by Product Type
      Inactivated Polio Vaccine (IPV)
      Oral Polio Vaccine (OPV)

      Market Segment by Application
      Public
      Private

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Poliovirus Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Poliovirus Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Poliovirus Vaccine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now